Child-sized hallucinogenic Tamiflu capsules receive EU approval

Arabian Business | Oct 21, 2007

The European Commission has approved smaller child sized Tamiflu (oseltamivir) capsules of 30 mg and 45 mg doses.

Until now, Roche’s Tamiflu was available in capsules containing a 75 mg dose of oseltamivir and as a powder for oral suspension for use in children. The new lower dose capsules provide a convenient alternative for the treatment and prevention of influenza types A and B in children one year and older.

Since the smaller capsules have a longer shelf life than the suspension formulation (five years vs. two years), they also offer an improved option for government pandemic stockpiling.

The lower dose Tamiflu capsules were approved by the US Food and Drug Administration (FDA) in July.

As well as being used to manage seasonal influenza, Roche expects the 30 mg and 45 mg capsules to be an important component in government pandemic preparedness.

. . .

Related

Ten Canadians die after taking bird flu vaccine

Health Canada warns of hallucinations among Tamiflu users

Bird Flu ‘buddies’ will feed hallucinogenic Tamiflu pills to Brits

Tamiflu May Cause Psychiatric Problems

Flu drug carries new warning after delirium reports

Tamiflu may lead to delirium and suicide

Tamiflu may get ‘abnormal behavior’ label

Company claims herbal treatment for bird flu

World Bank: Bird Flu Could Cost $2 Trillion

Rumsfeld’s growing stake in Tamiflu

Rumsfeld To Profit From Bird Flu Hoax

Rumsfeld’s Pandemic Connection